Safety in the use of dexmedetomidine (precedex) for deep brain stimulation surgery: our experience in 23 randomized patients
- PMID: 22780449
- DOI: 10.1111/j.1525-1403.2012.00483.x
Safety in the use of dexmedetomidine (precedex) for deep brain stimulation surgery: our experience in 23 randomized patients
Abstract
Objective: Evaluation of safety and efficacy of dexmedetomidine in deep brain stimulation (DBS) surgery.
Materials and methods: A cohort of 23 patients, candidates for DBS for Parkinson's disease, Tourette syndrome, or obsessive-compulsive disorder, was randomized in two groups: dexmedetomidine group and control group. Standard anesthesiologic parameters were recorded and analyzed, together with the need for other medications. A ten-degree scale (visual analog scale) assessing patient discomfort during DBS also was recorded at the end of surgery.
Results: The results demonstrated good stability of intraoperative monitoring: no respiratory depression and good overall cooperation with the neurologist, while no side-effects were recorded.
Conclusions: Our conclusion is that dexmedetomidine should be considered as a valuable option for sedation in poorly collaborating patients undergoing DBS surgery.
Keywords: anesthesiology; deep brain stimulation; dexmedetomidine; safety; sedation.
© 2012 International Neuromodulation Society.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
